Nasdaq(NDAQ)
Search documents
Anthropic发布新AI 金融服务公司承压
Di Yi Cai Jing· 2026-02-05 23:26
Core Insights - Anthropic has released a new version of its AI model, Claude Opus 4.6, designed for financial research, which can analyze corporate data, regulatory filings, and market information to generate detailed financial analysis reports that typically take days for humans to complete [1] - The announcement of Claude Opus 4.6 has led to a significant decline in the stock prices of financial services companies, with FactSet Research Systems Inc. experiencing a drop of up to 10%, alongside notable declines in the stocks of S&P Global, Moody's, and Nasdaq [1] Company Impact - The introduction of Claude Opus 4.6 enhances various office functions, including spreadsheet creation, presentation development, and software programming, indicating a broader application of AI in financial services [1] - The market reaction to the release suggests a growing concern among investors regarding the potential disruption caused by advanced AI tools in traditional financial analysis roles [1]
Nasdaq 2026 Investor Day
Globenewswire· 2026-02-05 21:05
NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nasdaq will hold its 2026 Investor Day at the company’s Global Headquarters in Times Square, New York. Due to limited capacity, in-person attendance is by invitation only. When: Wednesday, February 25, 2026 8:00 AM – 12:30 PM ETWhere:Webcast registration link: https://edge.media-server.com/mmc/p/u69c26de The agenda, slide presentation and a live webcast will be available on the day of the event on Nasdaq’s IR website: http://ir.nasdaq.com. A replay will be avai ...
纳斯达克拟推快速纳入新规
Bei Jing Shang Bao· 2026-02-05 16:37
Core Viewpoint - Nasdaq has proposed a rule change to accelerate the inclusion of newly listed large-cap companies into its stock benchmark index, allowing them to be added to the Nasdaq-100 index after just 15 trading days, significantly shorter than the current waiting period of at least three months [1][2]. Group 1: Proposed Changes - The new "fast entry" rule aims to address the issue of large tech companies being overlooked by indices shortly after their IPOs [1]. - This change is designed to ensure that the largest non-financial companies listed on Nasdaq can be included in the index in a timely manner, reflecting the current market conditions [1][2]. - The adjustment is particularly relevant as many companies are choosing to stay private longer, leading to substantial market valuations at the time of their IPOs [2]. Group 2: Market Impact - The Nasdaq-100 index, which consists of 100 selected stocks across technology, media, and consumer goods, has become a key market indicator, especially with the recent surge in large tech stocks driven by the AI boom [2]. - Over $600 billion in ETFs are directly benchmarked to the Nasdaq-100, making the index's size a significant factor in attracting companies to go public [2]. - The proposed changes come at a time when major tech companies, including SpaceX with a potential valuation of $1.3 trillion, are expected to go public this year [3]. Group 3: Strategic Intent - The proposed rule change is seen as a strategic move by Nasdaq to enhance its appeal to new listings amid competition with the New York Stock Exchange for IPO resources [3]. - By allowing new companies to quickly gain passive fund allocations, Nasdaq aims to strengthen its position in attracting new IPOs [3]. - The adjustment to the free float requirement, which eliminates the minimum 10% threshold but introduces a new method for including companies with low free float, reflects a strategy to keep large companies in the index despite lower liquidity [4].
Nasdaq Reports January 2026 Volumes
Globenewswire· 2026-02-04 21:05
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for January 2026 on its Investor Relations website. A data sheet showing this information can be found at: https://ir.nasdaq.com/financials/volume-statistics. About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading technology platform that powers the world’s economies. We architect the world’s most modern markets, power the innovation economy, and build trust in the financial system. We empower economic opportunity by ...
Nasdaq, Inc. (NDAQ): A Bull Case Theory
Yahoo Finance· 2026-02-04 21:01
We came across a bullish thesis on Nasdaq, Inc. on Stay Invested’s Substack by Denis Gorbunov. In this article, we will summarize the bulls’ thesis on NDAQ. Nasdaq, Inc.'s share was trading at $98.71 as of January 28th. NDAQ’s trailing and forward P/E were 35.18 and 26.18 respectively according to Yahoo Finance. 10 Buzzing AI Stocks on Wall Street Photo by Pascal Bernardon on Unsplash Nasdaq, Inc. operates as a technology company that serves capital markets and other industries worldwide. NDAQ is levera ...
Nasdaq proposes 'fast entry' rule to speed up inclusion of large new listings
The Economic Times· 2026-02-04 13:49
The proposal comes as 2026 is shaping up to be one of the busiest years for new and some big listings, including IPO plans from Elon Musk's SpaceX and artificial intelligence startup Anthropic. Under the proposed "Fast Entry" rule, a newly Nasdaq-listed company whose market capitalization ranks among the top 40 current index constituents would be eligible for accelerated inclusion, with at least five trading days' notice and entry after 15 sessions. The company would be exempt from standard seasoning a ...
Nasdaq Mulls New ‘Fast Entry’ Rule Ahead of Big IPOs Like SpaceX
Yahoo Finance· 2026-02-04 12:00
Core Viewpoint - Nasdaq is proposing a "fast entry" rule to allow newly listed large-cap firms to join the Nasdaq 100 Index after just 15 trading days, significantly reducing the current waiting period of at least three months [1][6]. Group 1: Proposed Changes - The "fast entry" rule aims to adapt to the longer waiting times companies experience before going public, allowing for quicker inclusion of significant market value into the index [2][3]. - The proposed change is part of an industry consultation that will conclude later this month, with potential implementation after the quarterly rebalance in March [6]. Group 2: Market Impact - The Nasdaq 100 Index is benchmarked to over $600 billion in exchange-traded funds globally, making it a crucial gauge for the stock market, especially amid the AI boom benefiting large tech companies [3][7]. - Companies like SpaceX, with a potential valuation of $1.3 trillion, are expected to go public this year, which would significantly impact the Nasdaq 100 if included quickly [2]. Group 3: Competitive Landscape - Other index managers, such as MSCI, have already adopted faster inclusion methods for large IPOs, highlighting the competitive pressure on Nasdaq to attract new listings [5]. - The proposed changes are seen as a way to make the index more representative of the market in a timely manner, addressing concerns from passive fund managers about missing out on new stock rallies [3][7].
Japan's Osaka Exchange Adopts Nasdaq Eqlipse Trading and Surveillance Technology for Next-Generation Derivatives Platform
Globenewswire· 2026-02-04 07:18
Core Insights - Nasdaq has been selected by Osaka Exchange (OSE) to provide advanced Eqlipse Trading and Market Surveillance technology platforms, marking a significant step in OSE's modernization efforts and enhancing Japan's competitiveness in the global derivatives market [1][2][3] Group 1: Technology Partnership - The partnership with Nasdaq is expected to strengthen OSE's derivatives trading foundation, providing a safer and more efficient trading environment for all market stakeholders [2] - Nasdaq's technology will enable OSE to rapidly deploy new products and services, efficiently manage volume fluctuations, and maintain high performance standards [2][5] Group 2: Market Integrity and Performance - The integration of Nasdaq Market Surveillance technology will enhance OSE's market integrity framework, utilizing advanced analytics and AI to detect potential market abuse [6] - The Eqlipse Trading platform will support multi-asset trading with ultra-low latency, providing robust risk management tools and market-standard APIs [5] Group 3: Commitment to Modernization - OSE's modernization program reflects a commitment to world-class market infrastructure that adapts to evolving market dynamics while ensuring operational excellence [4][8] - Nasdaq's long-standing partnership with Japan's financial services ecosystem underscores its role in supporting the modernization and growth of Japan's capital markets [7][8] Group 4: Global Technology Leadership - Nasdaq's technology is utilized by major global financial institutions, including systematically important banks and stock exchanges, showcasing its leadership in market infrastructure [10]
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
Globenewswire· 2026-02-03 21:05
Core Viewpoint - Adial Pharmaceuticals, Inc. will implement a 1-for-25 reverse stock split to comply with Nasdaq's minimum bid price requirement and enhance its capital markets profile [1][3][4] Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of outstanding shares from approximately 27.8 million to about 1.1 million, while maintaining the ownership percentage of each shareholder [2] - The reverse stock split will take effect on February 5, 2026, at 11:59 p.m. Eastern Time, with trading on a split-adjusted basis starting February 6, 2026 [1][2] - There will be no change to the total number of authorized shares as per the Company's Certificate of Incorporation [2] Group 2: Strategic Intentions - The reverse stock split aims to bring the Company into compliance with Nasdaq's minimum bid price requirement of at least $1.00 per share [3] - The action is expected to make the bid price more attractive to a wider range of institutional and retail investors [3][4] - The Company remains optimistic about its future and is focused on advancing its lead product, AD04, for the treatment of Alcohol Use Disorder [4][5] Group 3: Company Overview - Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies for addiction and related disorders [5] - The lead investigational drug, AD04, is a genetically targeted serotonin-3 receptor antagonist aimed at treating Alcohol Use Disorder in heavy drinking patients [5] - The Company plans to conduct a new Phase 3 clinical trial program for AD04, which has shown promising results in reducing drinking without significant safety concerns [5]